TH5487 decreases RSV replication in lungs. by Lang Pan (5145221)

Table 3 - Sportspersonship orientation in the training process of young football players in different training contexts by Gema Ortega Vila (19870900)

Subjects:

Different steps of the fabrication process. by Md. Abu Daud (21485629)

Production and metabolic processes for dimethylarginine. by Afeefa Zainab (20141773)

Differences in mean number of papers (top) and co-authors (bottom) depending on (1) NI membership and (2) time joined NI. by William C. Barley (8915282)

Evolution of mean values of posttraumatic stress symptomatology according to sociodemographic and occupational variables from baseline to 12-month. by Beatriz Arregui-Gallego (21553735)

Mean ± SD of the different parameters relative to bipedal stance on soft support with the eyes open recorded in the Chewing and Hand Grip groups. by Cristina Dolciotti (16317330)

Local consumer escalation process (adapted from Local Health Network (CALHN) procedure 2019) [16]. by Lisa Thiele (6468056)

Subjects:

Forest plots illustrate the mean difference in creatinine level with subgroup analysis based on patients’ age. by Mohamed R. Abdelraouf (21501468)

Mycosis rates (mean % ± SE) of aphids exposed to entomopathogenic fungi from four agroecological zones. by Aime Cheoh Enoh (20141758)

Results of the mediation model test for the elevated inhibition function in the relationship between elevated mindfulness level and decreased mobile phone addiction index. by Jizhao Li (5856650)

Graphs showing the mean maximum temperature increase at the position with the highest mean temperature increase (A) and the mean temperature increase across all probes (B) for each... by Marsel Ganeyev (21453399)

Image 2_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Image 1_Case report: Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis.jpeg by David Qixiang Chen (8198265)

“…Ibogaine, a psychoactive alkaloid, has been proposed as a potential neuroregenerative agent due to its multifaceted pharmacological profile. We present two case studies of MS patients who underwent a novel ibogaine treatment, highlighting significant neuroimaging changes and clinical improvements. …”

Mean of the difference between the RV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Mean of the difference between the LV-GLS value of the expert and trainees in four consecutive groups of 25 fetal heart clips. by Chantelle M. de Vet (16535257)

Bar graphs showing the means and 95% CI of each retinal layer thickness at each visit. by Jung-Tae Kim (8997767)

Mean 0-30 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI). by Murat Tutar (22250461)

Mean 0-20 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI). by Murat Tutar (22250461)

Mean 0-10 m sprint times for TSG, VBT, and CG groups at pre-test and post-test (with 95% CI). by Murat Tutar (22250461)